PCM
BIND

Prelude Capital Management’s BIND THERAPEUTICS INC BIND Stock Holding History

Prelude Capital Management’s Portfolio BIND Stock Details BIND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-26,000
Closed -$116K – 1937
2015
Q3 		$116K Hold
26,000
– – 0.02% 796
2015
Q2 		$145K Hold
26,000
– – 0.02% 768
2015
Q1 		$143K Buy
26,000
+10,000
+63% +$61.4K 0.02% 843
2014
Q4 		$86K Hold
16,000
– – 0.01% 1063
2014
Q3 		$137K Hold
16,000
– – 0.02% 909
2014
Q2 		$211K Buy
16,000
+3,000
+23% +$29.4K 0.03% 725
2014
Q1 		$155K Hold
13,000
– – 0.02% 826
2013
Q4 		$196K Buy
+13,000
New +$165K 0.03% 625

Other funds holding BIND

PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Prelude Capital Management's BIND Position: Q4 2015 in Review

Prelude Capital Management sold out of BIND THERAPEUTICS INC (BIND) in Q4 2015, closing a stake of 26,000 shares — an estimated $116K sold.

Prelude Capital Management first reported a position in BIND in Q4 2013 and held it in 8 quarters. The position peaked at $211K in Q2 2014. 38 funds tracked by Wall St. Rank hold BIND as of Q4 2015.

  • Prelude Capital Management reported no remaining BIND THERAPEUTICS INC position as of Q4 2015 after selling out during the quarter.
  • Prelude Capital Management sold 26,000 BIND THERAPEUTICS INC shares in Q4 2015, an estimated $116K.
  • Prelude Capital Management first reported a position in BIND THERAPEUTICS INC in Q4 2013 and held it in 8 quarters.
  • Prelude Capital Management's BIND THERAPEUTICS INC position peaked at $211K in Q2 2014.
  • 38 funds tracked by Wall St. Rank held BIND THERAPEUTICS INC as of Q4 2015.

Based on Prelude Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.